Webcast Understanding the Ripple Effect of Drug Pricing Reform

Understanding the Ripple Effect of Drug Pricing Reform

 · America/New_York

About This Webcast

The Inflation Reduction Act is doing more than cutting costs – it’s changing how life sciences organizations prove value, engage patients, and compete in a shifting market. This session explores the real-world ripple effects of pricing reform, including early data on the insulin cap, evolving patient behaviors, and what it all means for your market access strategy. Join us to discover: How IRA-driven pricing changes are influencing patient outcomes and behavior Best practices for building RWE that strengthens pricing, value, and policy positioning Ways to future-proof your evidence generation and market access plans Speakers: Christie Teigland, Ph.D., VP, Research Science and Advanced Analytics at Inovalon Razanne Oueini, Pharm.D., MSc, Senior Manager, Performance Measurement at Pharmacy Quality Alliance Rebecca Kirch, Executive Vice President, Policy and Programs at National Patient Advocate Foundation